HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

roscovitine

inhibits cdk2; structure in first source
Also Known As:
2-(1-ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine; CYC 202; CYC-202; CYC202; R-roscovitine; Seliciclib
Networked: 270 relevant articles (15 outcomes, 68 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wesierska-Gadek, Józefa: 17 articles (01/2011 - 09/2003)
2. Meijer, Laurent: 13 articles (01/2015 - 06/2003)
3. Maurer, Margarita: 10 articles (04/2011 - 10/2007)
4. Hassan, Moustapha: 7 articles (06/2015 - 02/2004)
5. Arisan, Elif Damla: 6 articles (06/2015 - 05/2012)
6. Sallam, Hatem: 6 articles (06/2015 - 11/2007)
7. Obakan, Pinar: 6 articles (06/2015 - 05/2012)
8. Galons, Hervé: 6 articles (01/2015 - 09/2005)
9. Komina, Oxana: 6 articles (04/2011 - 12/2008)
10. Lane, David P: 6 articles (01/2009 - 12/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Glomerulonephritis
3. Nephritis
4. Breast Neoplasms (Breast Cancer)
5. Multiple Myeloma

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Cyclins
3. Cyclin-Dependent Kinases (cdk Proteins)
4. flavopiridol
5. Doxorubicin (Adriamycin)
6. DNA (Deoxyribonucleic Acid)
7. Bromodeoxyuridine (BrdU)
8. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
9. Hormones
10. Mitogen-Activated Protein Kinase 3

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Injections
3. Drug Therapy (Chemotherapy)
4. Stents
5. Nephrectomy